Shigella Vaccines – Talk Bio

Actionable Insights Powered by AI

GSK Licenses Experimental Shigella Vaccine to Bharat Biotech for Development and Distribution

1 month ago talkbio0Tagged Bharat, biotech, GMMA platform, low, Microbicides, middle-income countries, Resistance (Psychotherapeutic), Shigella Infections, Shigella Vaccines, SmithKline Beecham, vaccine licensing

GSK; Bharat Biotech; Shigella vaccine; altSonflex1-2-3; vaccine licensing; Shigellosis; GMMA platform; antimicrobial resistance; low and middle-income countries

Valneva Invests $10M in LimmaTech for Clinical-Stage Shigella Vaccine

12 months ago talkbio0Tagged clinical-stage, development aspects, LimmaTech, Shigella Vaccines, Vaccines, Valneva

Valneva, LimmaTech, Shigella vaccine, clinical-stage, biotech, pharmaceuticals, vaccine development